Ann: Imugene completes $90 M placement and launches $5 M SPP, page-247

Our market is worth less now, I agree. But I did say there is a cap raise tantrum here. Wait till it settles down and then after a couple of announcements, and off we will go. It happened before when it was a mere couple of cents and it will happen again. I am of course assuming the company is on track with some of its current trials.

Regarding cash balance, it is important for big pharma if they are going to have dance with us. They would want to ensure we have the stamina to do the whole dance. Otherwise, yes, if they are truly interested in our IP, then they would just swallow us whole and not bother to take risk partnering and we letting them down later on. One can't assume the capital is always there to be tapped on. What if when it is needed, there is a real depression. Like the recent Covid, and if you are a mere spec, probably impossible to raise any real capital of substance.